ID   UIA-MM4
AC   CVCL_M479
SY   UIA-MM 4; Universitaire Instelling Antwerpen-Malignant Mesothelioma 4
DR   Wikidata; Q54990176
RX   PubMed=9072005;
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
RX   PubMed=9072005; DOI=10.1002/(SICI)1096-9896(199701)181:1<67::AID-PATH723>3.0.CO;2-Z;
RA   Kumar-Singh S., Segers K., Rodeck U., Backhovens H., Bogers J.,
RA   Weyler J., Van Broeckhoven C., Van Marck E.;
RT   "WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in
RT   relation to p53 and growth factor receptor expression, cell-type
RT   transition, and prognosis.";
RL   J. Pathol. 181:67-74(1997).
//